Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey

Cancer Causes and Control

Volumn 21, Issue 4, 2010, Pages 631-642

  Parekh, Niyati ^a   Lin, Yong ^b,c   Hayes, Richard B ^a,d   Albu, Jeanine B ^e   Lu Yao, Grace L ^b,c,f  

^a NEW YORK UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NYU School of Medicine ^*  (United States)

^f ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cancer mortality; Epidemiology; Hyperglycemia; Insulin; Longitudinal study

Indexed keywords

C PEPTIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BODY MASS; BREAST CANCER; CANCER CONTROL; CANCER MORTALITY; COLON CANCER; CONTROLLED STUDY; DEATH CERTIFICATE; DEMOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; LIFESTYLE; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; FEMALE; GLUCOSE; HEALTH SURVEYS; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; LIPIDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; NUTRITION SURVEYS; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 77953286864     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9492-y     Document Type: Article

References (60)

1. Jemal A, Siegel R, Ward E et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96
2. US Mortality Data (2006) 1960-2004, National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, GA and National Center for Health Statistics, Hyattsville, MD pp 1-754
3. Jemal A, Siegel R, Ward E et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106-130
4. Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6(2): 164-179
5. Reaven GM (1991) Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 14(3): 195-202
6. Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23(38):6365-6378
7. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291(23):2847-2850 (Pubitemid 38747805)
8. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295(13):1549-1555
9. Vainio H, Kaaks R, Bianchini F (2002) Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev 11(Suppl 2):S94-S100 (Pubitemid 35265868)
10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17): 1625-1638 (Pubitemid 36459468)
11. Komninou D, Ayonote A, Richie JP Jr, Rigas B (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 228(4):396-405 (Pubitemid 37203647)
12. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1):S4-S6
13. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ (2003) Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomark Prev 12(5):412-418 (Pubitemid 36578478)
14. Rinaldi S, Rohrmann S, Jenab M et al. (2008) Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 17(11):3108-3115
15. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293(2):194-202
16. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B (2008) Elevated HbAlc is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci 53(9):2486-2494
17. Jullumstro E, Kollind M, Lydersen S, Edna TH (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol 48(3): 361-367
18. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12): 1160-1167
19. Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H (2008) Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. J Epidemiol 18(5):197-203
20. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomark Prev 10(9):937-941
21. Goodwin PJ, Ennis M, Pritchard KI et al. (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20(1):42-51
22. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomark Prev 11(4):385-391
23. Jaggers JR, Sui X, Hooker SP et al. (2009) Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer 45(10):1831-1838
24. National Center of Health Statistics (1995) Plan and operation of the third National Health and Nutrition Examination Survey, 1988-1994. National Center of Health Statistics, Hyattsville, MD, pp 1-754
25. Executive summary of the third report of the National Cholesterol Education Program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486-2497
26. Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville
27. Standards of medical care in diabetes (2008) Diabetes Care. Suppl 1:S12-S54
28. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS (2008) Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 207(6):928-934
29. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27(6): 1487-1495
30. Yokoyama H, Emoto M, Fujiwara S et al. (2004) Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab 89(3):1481-1484
31. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6(4):299-304
32. Mack R, Skurnick B, Sterling-Jean Y, Pedra-Nobre M, Bigg D (2003) Fasting insulin levels as a measure of insulin resistance in American Blacks. J Med 34(1-6):31-38
33. Bonser AM, Garcia-Webb P (1984) C-peptide measurement: methods and clinical utility. Crit Rev Clin Lab Sci 19(4):297-352
34. World Health Organization (1995) World Health Organization physical status: the use and interpretation of anthropometry. World Health Organization, Geneva
35. National Center for Health Statistics (2007) NHANES III linked mortality public-use file: detailed notes for selected variables. http://www.cdc.gov/nchs/ data/datalinkage/file-layout-nh3.pdf. Accessed on 4 Jan 2010
36. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225-249
37. Papanas N, Giatromanolaki A, Galazios G, Maltezos E, Sivridis E (2006) Endometrial carcinoma and diabetes revisited. Eur J Gynaecol Oncol 27(5):505-508
38. Hammarsten J, Hogstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41(18):2887-2895
39. Barone BB, Yeh HC, Snyder CF et al. (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754-2764
40. Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121(1):29-40
41. Okumura M, Yamamoto M, Sakuma H et al. (2002) Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 1592(2): 107-116
42. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB (2001) Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 21(17):5899-5912
43. Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131(11 Suppl):3109S-3120S
44. Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycemia and cancer development. Arch Physiol Biochem 115(2):86-96
45. Semple RK, Sleigh A, Murgatroyd PR et al. (2009) Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119(2):315-322
46. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential rale for cytokines originating from adipose tissue? Arterioscler Thramb Vase Biol 19(4):972-978
47. Choi KM, Ryu OH, Lee KW et al. (2006) Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract
48. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291(5):585-590 (Pubitemid 38500312)
49. Il'yasova D, Colbert LH, Harris TB et al. (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomark Prev 14(10):2413-2418
50. Bahia L, Aguiar LG, Villela N et al. (2006) Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 61(5)433-440
51. Grivennikov SI and Karin M (2009) Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20:1-7
52. Michaud DS, Wolpin B, Giovannucci E et al. (2007) Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomark Prev 16(10):2101-2109
53. Wei EK, Ma J, Pollak MN et al. (2005) A prospective study of Cpeptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomark Prev 14(4):850-855
54. Ma J, Giovannucci E, Pollack M et al. (2004) Prospective study of plasma C-peptide and colorectal cancer risk in men J Nat Cancer Inst 96:546-553
55. Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Smith GD (2005) Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond) 29(10): 1267-1274
56. Percy C, Stanek E III, Gloeckler L (1981) Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71(3):242-250
57. Melamed ML, Michos ED, Post W, Astor B (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15): 1629-1637
58. Saydah S, Graubard B, Ballard-Barbash R, Berrigan D (2007) Insulin-like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 166(5):518-526
59. Zhang Q, Wang Y, Huang ES (2009) Changes in racial/ethnic disparities in the prevalence of Type 2 diabetes by obesity level among US adults. Ethn Health 9:1-19
60. Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF (2007) The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med 45(5):348-352